Fungal Cell Wall: Emerging Antifungals and Drug Resistance
The cell wall is an essential component in fungal homeostasis. The lack of a covering wall in human cells makes this component an attractive target for antifungal development. The host environment and antifungal stress can lead to cell wall modifications related to drug resistance. Antifungals targe...
Main Authors: | Soraia L. Lima, Arnaldo L. Colombo, João N. de Almeida Junior |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-11-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmicb.2019.02573/full |
Similar Items
-
Ibrexafungerp: A First-in-Class Oral Triterpenoid Glucan Synthase Inhibitor
by: Sabelle Jallow, et al.
Published: (2021-02-01) -
Ibrexafungerp, a Novel Oral Triterpenoid Antifungal in Development: Overview of Antifungal Activity Against Candida glabrata
by: Ahmed Gamal, et al.
Published: (2021-03-01) -
Novel Cell Wall Antifungals Reveal a Special Synergistic Activity in pbr1 Mutants Resistant to the Glucan Synthesis Antifungals Papulacandins and Echinocandins
by: Rodrigo Berzaghi, et al.
Published: (2019-07-01) -
Ibrexafungerp: A Novel Oral Triterpenoid Antifungal in Development for the Treatment of <i>Candida auris</i> Infections
by: Mahmoud Ghannoum, et al.
Published: (2020-08-01) -
Using Aspergillus nidulans to study alpha-1,3-glucan synthesis and the resistance mechanism against cell wall targeting drugs
Published: (2014)